4
Changes in Ownership
Xenon Pharmaceuticals Inc. Filed Acc 0001209191-22-058916
Director sold 3,994 shares at an average $34.55 ($138,000)
- Director acquired 2,057 shares (option exercise)
- Director gave up 120 shares (to pay taxes)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| PATOU GARY Director | 2022-11-23 | Sale | −2,057 | $34.33 | $70,610 | 23,573 | D: show line 1 in the form |
| PATOU GARY Director | 2022-11-25 | Option exercise | +2,057 | $2.68 | $5,513 | 25,630 | D: show line 2 in the form |
| PATOU GARY Director | 2022-11-25 | Shares withheld for taxes | −120 | $34.37 | $4,124 | 25,510 | D: show line 3 in the form |
| PATOU GARY Director | 2022-11-25 | Sale | −1,937 | $34.79 | $67,390 | 23,573 | D: show line 4 in the form |
| Open-market sales · 3,994 sh · avg $34.55 · $138,000 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| PATOU GARY Director | 2022-11-25 | Option exercise · Stock Option (Right to Buy) | −2,057 | 0 | D: show line 5 in the form |
Loading xslF345X03/doc4.xml…